Grünewald A, Ahlenstiel-Grunow T, Arslan Z, Battelino N, Rachisan ALB, Bouts A, Busutti M, Cornelissen E, de Jong H, Dudley J, Düzova A, Eibensteiner F, Fichtner A, Fomina S, Gonzalez ML, Gulhan B, Grabitz C, Hogan J, Höcker B, Jeruschke S, Kanzelmeyer N, Kim JJ, Korst U, Labbadia R, Litwin M, Marks S, Melk A, Novljan G, Obrycki L, Oh J, Pape N, Pasini A, Patry C, Pohl M, Preka E, Prytula A, Rieger S, Schiffer M, Schild R, Seeman T, Stojanovic J, Testa S, Tönshoff B, Torres DD, Weber LT, Nothacker M, Pape L (2026)
Publication Type: Journal article
Publication year: 2026
Book Volume: 110
Pages Range: e1889-e1915
Journal Issue: 9
DOI: 10.1097/TP.0000000000005772
Background. – There is a lack of robust evidence regarding immunosuppressive therapy in children and adolescents after kidney transplantation (KTx), and as such, international practice is highly variable. Recent clinical practice recommendations advocating individualized immunosuppressive strategies that incorporate newer agents are often not implemented. This can potentially contribute to reduced patient and renal allograft survival. Methods. – The guideline was developed between January 1, 2024, and December 12, 2025, according to the Guidance Manual of the German Association of Scientific Medical Societies by the German Societies for Pediatric Nephrology, Nephrology, Transplantation, and Pediatrics, the German Kidney Association, the International Pediatric Transplant Association, the European Society for Pediatric Nephrology and the Members of the Cooperative European Pediatric Renal Transplant Initiative. Results. – This evidence- and consensus-based guideline provides up-to-date, state-of-the-art recommendations for immunosuppressive therapy after KTx in pediatric kidney transplant recipients. It is based on the best available evidence and the consensus of the relevant German Medical Societies, Members of the Cooperative European Paediatric Renal Transplant Initiative, and the working group on transplantation of the European Society for Paediatric Nephrology, and the International Pediatric Transplant Association. Conclusions. – The formal consensus reached is particularly significant in cases of weak or inconclusive evidence and where recommendations are based solely on expert opinion.
APA:
Grünewald, A., Ahlenstiel-Grunow, T., Arslan, Z., Battelino, N., Rachisan, A.L.B., Bouts, A.,... Pape, L. (2026). Evidence- and Consensus-based European Guideline for Immunosuppressive Therapy After Pediatric Kidney Transplantation. Transplantation, 110(9), e1889-e1915. https://doi.org/10.1097/TP.0000000000005772
MLA:
Grünewald, Anna, et al. "Evidence- and Consensus-based European Guideline for Immunosuppressive Therapy After Pediatric Kidney Transplantation." Transplantation 110.9 (2026): e1889-e1915.
BibTeX: Download